Warning! GuruFocus detected
4 Severe warning signs
with A1H.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Amoeba SA
ISIN : FR0011051598
Compare
Compare
Traded in other countries / regions
ALMIB.France0RAE.UKA1H.Germany IPO Date
2018-04-05Description
Amoeba SA is a France-based company engaged in developing, producing, and commercializing a biological biocide for use in the industrial sector. It develops Biomeba, a green biocide that harnesses the biocidal properties of Willaertia magna, which is used to treat cooling towers.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.06 | |||||
Equity-to-Asset | -1.16 | |||||
Debt-to-Equity | -1.31 | |||||
Debt-to-EBITDA | -0.78 | |||||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 0.9 | |||||
3-Year EPS without NRI Growth Rate | 17.1 | |||||
3-Year FCF Growth Rate | -8.8 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 17.4 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 43.69 | |||||
9-Day RSI | 48.57 | |||||
14-Day RSI | 50.08 | |||||
3-1 Month Momentum % | -4.91 | |||||
6-1 Month Momentum % | 76.52 | |||||
12-1 Month Momentum % | 142.9 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.33 | |||||
Quick Ratio | 0.3 | |||||
Cash Ratio | 0.07 | |||||
Days Inventory | 65.18 | |||||
Days Payable | 129.11 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -44.8 | |||||
Shareholder Yield % | -12.75 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -675.55 | |||||
ROA % | -172.91 | |||||
ROIC % | -54.69 | |||||
3-Year ROIIC % | -45.9 | |||||
ROC (Joel Greenblatt) % | -371.34 | |||||
ROCE % | -733.77 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -4.08 | |||||
EV-to-EBITDA | -4.39 | |||||
EV-to-Forward-EBITDA | -6.02 | |||||
EV-to-FCF | -4.07 | |||||
Earnings Yield (Greenblatt) % | -24.51 | |||||
FCF Yield % | -29.44 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Amoeba SA Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -0.28 | ||
Beta | 0.25 | ||
3-Year Sharpe Ratio | 0.4 | ||
3-Year Sortino Ratio | 0.81 | ||
Volatility % | 60.28 | ||
14-Day RSI | 50.08 | ||
14-Day ATR (€) | 0.044518 | ||
20-Day SMA (€) | 0.8895 | ||
12-1 Month Momentum % | 142.9 | ||
52-Week Range (€) | 0.3405 - 1.054 | ||
Shares Outstanding (Mil) | 49.63 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Amoeba SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Amoeba SA Stock Events
Event | Date | Price (€) | ||
---|---|---|---|---|
No Event Data |
Amoeba SA Frequently Asked Questions
What is Amoeba SA(FRA:A1H)'s stock price today?
The current price of FRA:A1H is €0.91. The 52 week high of FRA:A1H is €1.05 and 52 week low is €0.34.
When is next earnings date of Amoeba SA(FRA:A1H)?
The next earnings date of Amoeba SA(FRA:A1H) is .
Does Amoeba SA(FRA:A1H) pay dividends? If so, how much?
Amoeba SA(FRA:A1H) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |